Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Glutathione peroxidase 4 (GPX4) is a selenium-dependent enzyme that protects cells from oxidative damage by reducing lipid hydroperoxides within biological membranes. It is a central regulator of ferroptosis, a form of iron-dependent cell death, and its inactivation leads to the accumulation of toxic lipid peroxides. GPX4 plays roles in inflammation resolution and eicosanoid biosynthesis. It has emerged as an important pharmacological target, with inhibitors being investigated for their ability to induce ferroptosis in therapy-resistant cancer cells.
GPX4 inhibitors induce ferroptosis by preventing the reduction of lipid hydroperoxides, leading to their accumulation and subsequent cell death.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Glutathione Peroxidase 4 (GPX4).